Protocols and targets | BERLIN | BERLIN E | BERLIN RdRp | HKU | HKU N | HKU Orf1b | DAAN Gene® | DAAN Gene® N | DAAN Gene® Orf1ab | IPP | IPP IP2 | IPP IP4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
“Positive”: target amplification by both targets per protocol | POSITIVE n(%) | n = 116 (44.6%) | 116 (100%) | 116 (100%) | n = 112 (43.1%) | 112 (100%) | 112 (100%) | n = 143 (55%) | 143 (100%) | 143 (100%) | n = 89 (35%) | 89 (100%) | 89 (100%) |
Ct value Median [min, max] | 29 [16.39] | 31 [18.39] | 28[12.39] | 27.5[16.39] | 25[13.39] | 28[16.39] | 27[15.38] | 27[15.39] | |||||
Ct value mean +/− SD | 28.9 +/− 5.2 | 30.5 +/− 4.8 | 27.4 +/− 5.9 | 27.5 +/− 5.9 | 26.2 +/− 6.6 | 28.5 +/− 6.1 | 27.4 +/− 5.8 | 27.4 +/− 6.4 | |||||
MEAN PAIRED DIFFERENCE +/− SD | 1.5 +/− 2 | 0.2 +/− 1.9 | 2.3 +/− 2 | 0.04 +/− 1.6 | |||||||||
PAIRED SAMPLE t-TEST | p < 0.0001 | p = 0.3 | p < 0.0001 | p = 0.8 | |||||||||
« Partial positive» Target amplification by one target per protocol | POSITIVE n (%) | n = 17 (6.5%) | 15 (88.2%) | 2 (11.7%) | n = 17 (6.5%) | 15 (88.2%) | 2 (11.7%) | n = 39 (15%) | 37 (94.9%) | 2 (5.1%) | n = 44 (16.9%) | 38 (86.4%) | 6 (13.6%) |
Ct value Median [min, max] | 37[24. 39] | 33.5[33. 34] | 36[31.38] | 38[37.39] | 38[35.39] | 39[39.39] | 24.5[15.38] | 33.5[32.38] | |||||
Ct value mean +/− SD | 36 +/− 3.8 | 33.5 +/− 0.7 | 36 +/− 1.9 | 38 +/− 1.4 | 37.7 +/− 1.2 | 39 +/− 0 | 25.2 +/− 6.4 | 34.3 +/− 2.2 | |||||
NEGATIVE n (%) | 2 (11.7%) | 15 (88.2%) | 2 (11.7%) | 15 (88.2%) | 2 (5.1%) | 37 (94.9%) | 6 (13.6%) | 38 (86.4%) | |||||
« NEGATIVE» No target amplification by both targets per protocol, n(%) | n = 127 (48.8%) | 127 (100%) | 127 (100%) | n = 131. (50.4%) | 131 (100%) | 131 (100%) | n = 78 (30%) | 78 (100%) | 78 (100%) | n = 125 (48.10%) | 127 (100%) | 127 (100%) | |
Total | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) | 260 (100%) |